Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to ease tough choices about prenatal genetic tests

NCT ID NCT07225595

Knowledge-focused Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This study interviews pregnant patients and their healthcare providers to understand what information and support they need when deciding about prenatal genetic tests. The goal is to create practical resources that help patients make informed choices as testing options keep changing. About 78 participants will take part in interviews to share their experiences.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better support tools and strategies to help pregnant patients make informed choices about prenatal genetic testing.
What could go wrong
This is a small, early-stage interview study (78 participants) that aims to gather opinions, not test a treatment. The findings may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

78 people

The number who actually took part.

Started

Jan 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Group 1 participants include those who are in their 1st or 2nd trimester of pregnancy or are 1-12 months post partum (Groups 1A, 1B and 1C). These participants will be seeking prenatal or postpartum care at one of the participating study sites. Group 2 participants will be practicing and seeing patients at one of the study sites outpatient locations.

Ages

18 years and older

Sex

Female participants only

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Group 1 Inclusion Criteria: 1. 18 years of age or older 2. Ability to read and speak English 3. Able to provide consent to participate in the study 4. Have a viable intrauterine pregnancy (IUP) or 1-12 postpartum 5. Offered routine aneuploidy screening and diagnostic testing 6. Seeking care at one of the participating study sites Group 1 Exclusion Criteria: 1. \<18 years of age or older 2. Inability to read and speak English 3. Not able to provide consent to participate in the study 4. Does not have a viable intrauterine pregnancy (IUP) or is not 1-12 postpartum 5. Was not offered routine aneuploidy screening and diagnostic testing 6. Is not seeking care at one of the participating study sites Group 2 Inclusion Criteria: 1. Board eligible clinicians who provide prenatal care (includes OB/GYNs, CNMs, NPs, MFMs, GC, etc.) 2. Provide outpatient obstetric care 3. Practice at one of the study sites Group 2 Exclusion Criteria: 1. Not board eligible clinicians who provide prenatal care (includes OB/GYNs, CNMs, NPs, MFMs, GC, etc.) 2. Does not provide outpatient obstetric care 3. Does not practice at one of the study sites

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prenatal care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prenatal care Prenatal diagnosis

Contacts and locations

Locations

  • Cleveland Clinic

    Cleveland, Ohio, 44195, United States

  • MetroHealth Medical Center

    Cleveland, Ohio, 44109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.